Reuters

Roche wins Japan approval for personalized cancer drug Rozlytrek

Jun 18, 2019

By John Miller ZURICH (Reuters) – Swiss drugmaker Roche’s push into personalized...

AstraZeneca’s Lynparza gets EU nod as first-line ovarian cancer maintenance treatment

Jun 18, 2019

(Reuters) – British drugmaker AstraZeneca Plc on Tuesday said its cancer medicine Lynparza was approved as a first-line maintenance treatment for a type of advanced ovarian cancer by the European Commission, following a...

French drugmaker Sanofi, Google to use data tech for innovations

Jun 18, 2019

PARIS (Reuters) – French healthcare company Sanofi has teamed up with Google to work on...

Common nerve pain drug linked to suicidal behavior, overdose

Jun 17, 2019

By Anne Harding (Reuters Health) – A class of medications used for nerve and muscle pain, including the popular drug Lyrica, increases users’ risks for suicidal behavior, unintentional overdoses, injuries and car...

When elders leave hospital, falls are big reason they return

Jun 17, 2019

By Saumya Joseph (Reuters Health) – Preventing falls among elderly patients who’ve just left the hospital is an important part of keeping them safe, a large U.S. study shows. When elderly patients are discharged, one...

Genetics research gets help from social media

Jun 17, 2019

By Linda Carroll (Reuters Health) – Researchers have harnessed the power of social media to build a genetic database, according to a new report. The “Genes for Good” project, which turned to Facebook to recruit...

U.S. records 22 new measles cases, bringing year’s total to 1,044

Jun 17, 2019

By Gabriella Borter (Reuters) – The United States recorded 22 new measles cases last week,...

VBI’s shares plunge after hep B vaccine fails secondary goal in late-stage trial

Jun 17, 2019

By Manojna Maddipatla and Tamara Mathias (Reuters) – VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis B vaccine were as effective as three doses of an older vaccine...

Eleven U.S. cancer centers get to charge more for care

Jun 17, 2019

By Linda Carroll For several decades, certain cancer centers have been allowed by the U.S. government to charge more for the care they give. A new study finds the care given at these centers isn’t very different from that...

Israel’s Zebra Medical gets FDA ok for brain bleeds product

Jun 17, 2019

TEL AVIV (Reuters) – Zebra Medical Vision, an Israel medical imaging analytics company, said on Monday it received its third clearance from the U.S. Food and Drug Administration for its alert for intracranial hemorrhage,...

GSK pharma head flags need for speed in high-pressure drug market

Jun 17, 2019

By Ludwig Burger LONDON (Reuters) – Doing things one at a time in drug development is not a...

Brain fever kills 97 children in east India

Jun 17, 2019

NEW DELHI (Reuters) – Nearly 100 children have died this month from encephalitis, commonly...

eSwatini bans imports of live pigs from countries affected by African swine fever

Jun 17, 2019

MBABANE (Reuters) – The Kingdom of eSwatini, formerly known as Swaziland, banned imports of live pigs on Monday from countries that test positive for African Swine Fever (ASF) after an outbreak of the disease in...

Ebola’s spread shows how science needs societies to succeed

Jun 17, 2019

By Kate Kelland LONDON – The persistence of Congo’s Ebola outbreak and its deadly...

WHO likely to declare Ebola an international emergency: experts

Jun 15, 2019

By Stephanie Nebehay GENEVA (Reuters) – The World Health Organization (WHO) should and is...

WHO panel decides not to declare international Ebola emergency

Jun 15, 2019

By Stephanie Nebehay GENEVA (Reuters) – A World Health Organization panel decided on Friday not to declare an international emergency over Congo’s Ebola outbreak despite its spread to Uganda this week, concluding...